Medinotec Inc.
MDNCOTCHealthcare · Surgical & Medical Instruments & Apparatus · NV · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY26 | FY25 | FY24 | FY23 | FY22 | |
|---|---|---|---|---|---|
| Revenue | $9.7M | $9.1M | $5.0M | $999,579 | $1.0M |
| Operating income | $1.1M | $3.2M | $600,578 | −$238,587 | −$190,616 |
| Net income | $794,502 | $2.2M | −$404,688 | −$352,735 | −$123,999 |
| Total assets | $6.8M | $6.8M | $4.8M | $4.5M | $1.3M |
| Total liabilities | $1.1M | $2.5M | $2.6M | $1.9M | $1.8M |
| Equity | $5.7M | $4.3M | $2.2M | $2.6M | −$469,985 |
| EPS (diluted) | $0.07 | $0.18 | $-0.03 | $-0.03 | $0.01 |
| Shares out. | 11.8M | 11.7M | 11.7M | 11.7M | 10.0M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2026- Operating margin
- 11.2%
- Net margin
- 8.2%
- Return on equity
- 13.9%
- Return on assets
- 11.7%
- Return on capital (ROCE)
- 19.2%
- Liabilities / assets
- 16.2%
- Debt / equity
- 0.19×
- Book value / share
- $0.49
- Revenue growth (YoY)
- 6.8%
- Net income growth (YoY)
- −63.2%
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2026- Accruals / assets
- −1.6%clean
- Beneish M-Score
- -2.31normal
- Piotroski F-Score
- 6/9mixed
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast. What these scores mean →
Signs
● 1 severe● 5 good- Filed a late-filing notice (Form NT) — missed an SEC deadline
- Operating margin is positive
- Revenue is growing year-over-year
- Conservative leverage (liabilities < 50% of assets)
- Positive operating cash flow
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-Qmissed a reporting deadline ↗Jul 16, 2025
- NT 10-Kmissed a reporting deadline ↗May 29, 2024
- NT 10-Qmissed a reporting deadline ↗Jan 12, 2024
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
5%+ owners
SEC Schedule 13D / 13G · last 3 yrs- Vizirgianakis Stavros G.Activist (13D)Jun 12, 2025
- Vizirgianakis GregoryActivist (13D)Jun 12, 2025
Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.
Material events
SEC Form 8-K · most recent- Shareholder voteJan 20, 2026
- Regulation FD disclosureJan 27, 2025
- Changed auditorJul 10, 2024
- Shareholder voteMar 19, 2024
- Regulation FD disclosureFeb 26, 2024
- Director / officer changeOct 12, 2023
- Changed auditor · Other material eventJun 21, 2023
- Regulation FD disclosureMay 17, 2023
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- 10-KFORM 10-KMay 28, 2026
- 8-KFORM 8-KJan 20, 2026
- 10-QFORM 10-QJan 9, 2026
- DEF 14ADEFINITIVE PROXY STATEMENTJan 2, 2026
- 10-QFORM 10-QOct 8, 2025
- 10-QFORM 10-QJul 16, 2025
- NT 10-QJul 16, 2025
- 3Jun 17, 2025
- SCHEDULE 13DJun 12, 2025
- SCHEDULE 13DJun 12, 2025
- 3Jun 12, 2025
- 3Jun 12, 2025
- 10-KFORM 10-KMay 29, 2025
- 3May 22, 2025
- 3May 22, 2025
Event-driven situations (2)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.